Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Cipla
Julphar
UBS
Chinese Patent Office
Colorcon
McKinsey
Healthtrust
Accenture
Chubb

Generated: January 22, 2018

DrugPatentWatch Database Preview

TENORMIN Drug Profile

« Back to Dashboard

When do Tenormin patents expire, and when can generic versions of Tenormin launch?

Tenormin is a drug marketed by Astrazeneca and Alvogen Malta and is included in two NDAs.

The generic ingredient in TENORMIN is atenolol. There are thirty-three drug master file entries for this compound. Sixty-one suppliers are listed for this compound. Additional details are available on the atenolol profile page.

US Patents and Regulatory Information for TENORMIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca TENORMIN atenolol INJECTABLE;INJECTION 019058-001 Sep 13, 1989 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-004 Apr 9, 1990 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-001 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for TENORMIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-004 Apr 9, 1990 ➤ Subscribe ➤ Subscribe
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-004 Apr 9, 1990 ➤ Subscribe ➤ Subscribe
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Argus Health
Merck
Accenture
Mallinckrodt
Farmers Insurance
Boehringer Ingelheim
Federal Trade Commission
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot